Corvus Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Corvus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Corvus Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corvus Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.3M | 446k | 7.37 |
| 2025-03-31 | $2.8M | 868k | 3.18 |
| 2024-12-31 | $5.8M | 1.1M | 5.35 |
| 2024-09-30 | $4.6M | 876k | 5.28 |
| 2023-09-30 | $72k | 49k | 1.46 |
| 2023-06-30 | $216k | 94k | 2.29 |
| 2022-06-30 | $39k | 40k | 0.98 |
| 2022-03-31 | $116k | 71k | 1.64 |
| 2021-12-31 | $255k | 106k | 2.41 |
| 2021-09-30 | $121k | 25k | 4.85 |
| 2021-03-31 | $95k | 31k | 3.08 |
| 2020-12-31 | $291k | 82k | 3.56 |
| 2020-09-30 | $415k | 104k | 4.01 |
| 2020-06-30 | $311k | 114k | 2.72 |
| 2019-12-31 | $583k | 107k | 5.44 |
| 2019-09-30 | $180k | 60k | 3.01 |
| 2019-06-30 | $228k | 61k | 3.75 |
| 2019-03-31 | $109k | 27k | 4.02 |
| 2018-12-31 | $144k | 39k | 3.66 |
| 2018-09-30 | $335k | 39k | 8.59 |
| 2018-06-30 | $856k | 78k | 10.98 |
| 2018-03-31 | $406k | 35k | 11.53 |
| 2017-12-31 | $253k | 24k | 10.37 |
| 2016-12-31 | $173k | 12k | 14.29 |
| 2016-09-30 | $406k | 25k | 16.44 |
| 2016-06-30 | $157k | 11k | 14.26 |
| 2016-03-31 | $386k | 27k | 14.49 |